CSIMarket Company Name, Ticker, Competitors, else..
 
Pfizer Inc  (PFE)
Other Ticker:  
 
 

Pfizer Inc Growth Comparisons

Select each growth Category to receive further Information



PFE Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q1 MRQ) -28.76 % -8.24 % -4.76 % 1.97 %
Q / Q Revenue Growth (Q1 MRQ) -24.73 % 5.34 % 1.61 % -5.02 %
Y / Y Revenue Growth (for 12 months ending Q1 TTM) 0.63 % -4.08 % -0.31 % %
Seq. Revenue Growth (for 12 months ending Q1 TTM) -7.35 % -2.01 % -1.03 % 0.35 %
Revenue 5 Year Average Growth 13.81 % 14.11 % 10.68 % 11.14 %


PFE's Growth Comparisons in I. Quarter 2023




Pfizer Inc's Revenue were slashed by -28.76% in the first quarter 2023 from the same quarter a year ago, to $ 18.28 billions, while sales in theMajor Pharmaceutical Preparations industry fell only by -8.24%, and underperformed the -4.76% Revenue decrease in the Healthcare sector. Weak first quarter sales, in Major Pharmaceutical Preparations industry and within the Healthcare sector, were reflected in Pfizer Inc results which underperformed overall market.

Comparing company's Revenue to the forth quarter results, sales were lower by -24.73% . On the annual basis, average annual sales growth for Pfizer Inc is 13.81%, while S & P 500's including only Businesses with the first quarter 2023 results, average yearly sales growth is 11.14% over the past five years.


Growth Rates of PFE's Income in the first quarter 2023


PFE Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q1 MRQ) -32.34 % -16.86 % -6.22 % 2.92 %
Seq. Operating Income Change (Q1 MRQ) 32.25 % -34.11 % -27.29 % 1.83 %
Y / Y Operating Income Growth (Q1 TTM) 36.03 % 11.44 % -4.79 % 2.42 %
Seq. Operating Income Growth (Q1 TTM) -8.47 % -3.3 % 1.31 % 0.49 %
Operating Income 5 Year Avg. Change 21.39 % 33.63 % 10.52 % 11.25 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q1 MRQ) -29.5 % -67.76 % -25.44 % 2.27 %
Seq. Income from Cont. Ops. Change (Q1 MRQ) 11.08 % -49.62 % -24.83 % 16.52 %
Y / Y Income from Cont. Ops. Change (Q1 TTM) 14.2 % -25.49 % -32.73 % -0.93 %
Seq. Income from Cont. Ops. Change (Q1 TTM) -7.4 % -19.77 % -1.33 % 0.63 %
Income from Cont. Ops. 5 Year Avg. Change 8.02 % 56.44 % 23.54 % 3.43 %

PFE Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q1 MRQ) -29.4 % -67.78 % -22.23 % 2.09 %
Q / Q Net Income Growth (Q1 MRQ) 11.05 % -50.14 % -22.39 % 14.22 %
Y / Y Net Income Change (Q1 TTM) 16.33 % -22.91 % -29.85 % -1.62 %
Seq. Net Income Change (Q1 TTM) -7.37 % -19.32 % -0.53 % 0.61 %
Net Income 5 Year Avg. Growth 8.02 % 56.55 % 23.54 % 3.71 %

PFE's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q1 MRQ) -30 % -84.09 % -25.44 % 2.27 %
Seq. EPS from Cont. Ops. Change (Q1 MRQ) 10.19 % -71.71 % -24.83 % 16.52 %
Y / Y EPS from Cont. Ops. Change (Q1 TTM) 16.31 % - - -
Seq. EPS from Cont. Ops. Change (Q1 TTM) -7.51 % - - -1.09 %
EPS from Cont. Ops. 5 Year Avg. Growth 9.38 % 19.34 % 23.54 % 3.43 %



PFE EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q1 MRQ) -29.2 % -84.09 % -22.23 % 3.43 %
Q / Q EPS Net Growth (Q1 MRQ) 11.31 % -72 % -22.39 % 14.22 %
Y / Y EPS Net Change (for 12 months ending Q1 TTM) - - - -13.89 %
Seq. EPS Net Change (for 12 months ending Q1 TTM) -7.3 % - - -1.82 %
EPS Net 5 Year Avg. Change 9.22 % 56.55 % 23.54 % 3.71 %



Pfizer Inc's EPS went down by -29.2% from the same quarter a year ago, in the first quarter, to $ 0.97, and Major Pharmaceutical Preparations industry with -84.09% but underperformed the -22.23% EPS decline in the Healthcare sector. Slow first quarter 2023 income per share, in Major Pharmaceutical Preparations industry and within the Healthcare sector, were portrayed in Pfizer Inc results which underperformed overall market.

The bottom-line improved by 11.31% from the forth quarter. Looking into annual income per share rise of 9.22%, and S & P 500's average yearly income per share growth is 3.71% over the five years, including only Businesses with the first quarter 2023 earnings reports. Pfizer Inc grew faster than the market.

PFE Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q1 MRQ) -81.47 % -45.18 % -39.36 % 12.77 %
Seq. Free Cash Flow Change (Q1 MRQ) -91.67 % -68.44 % -64.97 % -65.46 %
Y / Y Free Cash Flow Change (Q1 TTM) -11.66 % 21.2 % 2.15 % 12.1 %
Seq. Free Cash Flow Change (Q1 TTM) -12.95 % 28.05 % 14.77 % 5.38 %
Free Cash Flow 5 Year Avg. Change 12.8 % 27.54 % 18.78 % 22.75 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q1 MRQ) 231.57 % - - -
Seq. Net Cash Flow Change (Q1 MRQ) - 150.65 % - -
Y / Y Net Cash Flow Change (Q1 TTM) -66.94 % - - -
Seq. Net Cash Flow Change (Q1 TTM) - - - -
Net Cash Flow 5 Year Avg. Change - - -0.54 % 51.48 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q1 MRQ) 77.14 % 35.52 % 24 % 17.15 %
Seq. Capital Expenditures Change (Q1 MRQ) -38.17 % -35.6 % -24.55 % -29.07 %
Y / Y Capital Expenditures Change (Q1 TTM) 84.32 % 93.11 % 36.18 % -2.37 %
Seq. Capital Expenditures Change (Q1 TTM) 13.36 % 90.85 % 30.26 % 7.24 %
Capital Expenditures 5 Year Avg. Change 7.86 % 13.12 % 9 % 9.15 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071